4.4 • 102.8K Ratings
🗓️ 1 March 2023
⏱️ 31 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
| 0:00.0 | From the New York Times, I'm Sabrina Tavernici, and I'm Michael Borgum. |
| 0:06.8 | This is The Daily. |
| 0:10.0 | Today, two stories. |
| 0:16.4 | First, my colleague Pam Bellock on why any day now, a federal judge in Texas could issue |
| 0:22.5 | an order to ban the pill used in more than half the abortions across the country. |
| 0:27.4 | And, Julian Barnes goes inside the Biden administration's plan to publicize secret |
| 0:34.2 | intelligence to ensure that China never enters the war in Ukraine on behalf of Russia. |
| 0:43.3 | It's Wednesday, March 1st. |
| 0:49.2 | All eyes are on the state of Texas where a federal district judge's opinion is expected |
| 0:53.5 | sooner than a case that could impact reproductive rights again. |
| 0:57.0 | Here, a group of anti-abortion doctors and medical organizations are suing the FDA, challenging |
| 1:02.6 | the approval of mythoprex, generically known as miffoprystone, part of a two drug regimen |
| 1:07.8 | commonly used for abortions. |
| 1:09.6 | The result, if you win, is that abortion access will be significantly limited. |
| 1:14.6 | Is that the goal of this lawsuit? |
| 1:16.2 | No, the goal of this lawsuit is to prick American women and girls from dangerous chemical |
| 1:20.3 | abortion drugs. |
| 1:21.3 | This is essentially a backdoor national abortion ban. |
| 1:24.9 | And what I mean by that is this affects states like California, New York, Illinois, Minnesota, |
| 1:30.6 | Colorado that have taken some of these. |
| 1:31.8 | When you allow male-order abortion drugs, like the FDA has done, you get these dangerous |
| 1:36.4 | chemical abortion drugs in the mail without ever seeing an abortion is even in person. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The New York Times, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The New York Times and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.